2013 Annual Meeting | S12 - Hemorrhagic Stroke
| 03:00 PM - 04:30 PM | Abstract |
001 - Global Cerebral Edema among Good Grade Patients with Intracerebral Hemorrhage. Results from the Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) Study
|
| 03:00 PM - 04:30 PM | Abstract |
002 - ICH Triage Score: Predictors of Safe Floor Admission for Patients with Intracerebral Hemorrhage
Kazuma Nakagawa, MD, FAAN |
| 03:00 PM - 04:30 PM | Abstract |
003 - MRI Detection of Cerebral Infarction in Subarachnoid Hemorrhage
Georgia Korbakis, MD |
| 03:00 PM - 04:30 PM | Abstract |
004 - The SAH Score: An Outcome Prediction Model
Robert G. Kowalski, MBChB, MS |
| 03:00 PM - 04:30 PM | Abstract |
005 - Surveillance Neuroimaging and Neurologic Examinations Influence Management after Intracerebral Hemorrhage
Matthew Maas, MD, FAAN |
| 03:00 PM - 04:30 PM | Abstract |
006 - Impact of Acute Cocaine Use on Aneurysmal Subarachnoid Hemorrhage
Tiffany Chang, MD |
| Robert D. Brown, Jr., MD, MPH, FAAN | Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care. |
| Lauren H. Sansing, MD | Dr. Sansing has nothing to disclose. |
| Paul A. Nyquist, MD, MPH, FAAN | Dr. Nyquist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for astra Zenneca. The institution of Dr. Nyquist has received research support from NIH. |
| Matthew Maas, MD, FAAN | The institution of Dr. Maas has received research support from National Institutes of Health. |
| Tanuja Chitnis, MD, FAAN | Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Siemens. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Academic CME. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover. |
| Shyam Prabhakaran, MD | Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. The institution of Dr. Prabhakaran has received research support from NIH . The institution of Dr. Prabhakaran has received research support from AHRQ. Dr. Prabhakaran has received publishing royalties from a publication relating to health care. |
| Andrew M. Naidech, MD, FAAN | The institution of Dr. Naidech has received research support from NIH. Dr. Naidech has received publishing royalties from a publication relating to health care. |
| Neil Rosenberg, MD | Dr. Rosenberg has nothing to disclose. |
| Vivien H. Lee, MD, FAAN | Dr. Lee has nothing to disclose. |
| Pratap R. Chand, MD, FRCP, FAAN | Dr. Chand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. An immediate family member of Dr. Chand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda. Dr. Chand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Neuroscience. |
| No disclosure on file | |
| James Conners, MD | The institution of Dr. Conners has received research support from nih. |
| Eric Liotta, MD | Dr. Liotta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Penumbra. The institution of Dr. Liotta has received research support from NIH-NINDS. |
| Tiffany Chang, MD | Dr. Chang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for National Football League. |
| Juan R. Carhuapoma, MD | Dr. Carhuapoma has nothing to disclose. |
| David A. Grimes, MD | No disclosure on file |
| Megan A. Vento | No disclosure on file |
| Claude Hemphill III, MD, FAAN | Dr. Hemphill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Hemphill has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Hemphill has received research support from NIH/NINDS. |
| Rajeev Garg, MD, FAAN | No disclosure on file |
| Georgia Korbakis, MD | No disclosure on file |
| Lauren B. Krupp, MD, FAAN | Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care. |
| Susan M. Asai | No disclosure on file |
| James Guth, MD | No disclosure on file |
| Ali Seddighzadeh | No disclosure on file |
| Florian P. Thomas, MD, PhD, MA, FAAN | Dr. Thomas has received personal compensation for serving as an employee of Hackensack Meridian Health. Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharnext. Dr. Thomas has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Spinal Cord Medicine. Dr. Thomas has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Gravel & Shae. The institution of Dr. Thomas has received research support from University of Pennsylavania. Dr. Thomas has a non-compensated relationship as a Board Member, Metro New Jersey with National MS Society that is relevant to AAN interests or activities. Dr. Thomas has a non-compensated relationship as a Board Member with American Paraplegia Society that is relevant to AAN interests or activities. |
| Neeraj Naval, MD | No disclosure on file |
| Kazuma Nakagawa, MD, FAAN | Dr. Nakagawa has nothing to disclose. |
| Matthew A. Koenig, MD | No disclosure on file |
| Thomas P. Bleck, MD, FAAN | Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Bleck has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for iECURE. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine. Dr. Bleck has received research support from NIH. |
| Richard E. Temes, MD | No disclosure on file |
| Emmanuelle Waubant, MD, PhD, FAAN | The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care. |
| Sayona John, MD, FAAN | Dr. John has nothing to disclose. |
| Robert G. Kowalski, MBChB, MS | The institution of Dr. Kowalski has received research support from Henry Ford Hospital. The institution of Dr. Kowalski has received research support from MaxQ. Dr. Kowalski has a non-compensated relationship as a Editor-in-Chief, newsletter with PRe-hospital Stroke Treatment Organization (PRESTO) that is relevant to AAN interests or activities. |
| Cherylee Chang, MD | No disclosure on file |